For the Inventor, By the Inventor

Enter assignee name

Huddinge, Sweden

Medivir Ab

USPTO Granted Patents = 120

CIPO Patents = 5

EPO Patents = 31

Trademarks = 1

Forward Citations = 803

Loading Chart...

Loading Chart...

184 inventors (with patents filed for the assignee):

Bengt Bertil Samuelsson (19 out of 24 patents)

Pierre Jean-Marie Bernard Raboisson (18 out of 178 patents)

Bertil Samuelsson (17 out of 17 patents)

4. Urszula Grabowska (14 out of 18 patents)

5. Åsa Annica Kristina Rosenquist (14 out of 18 patents)

6. Karl Magnus Nilsson (14 out of 18 patents)

7. Xiao-Xiong Zhou (14 out of 14 patents)

8. Magnus Nilsson (13 out of 14 patents)

9. Pia Kahnberg (13 out of 18 patents)

10. Abdellah Tahri (12 out of 61 patents)

11. Lili Hu (12 out of 37 patents)

12. Kenneth Simmen (12 out of 26 patents)

13. Nils-Gunnar Johansson (12 out of 12 patents)

14. Hans Kristian Wallberg (12 out of 16 patents)

15. Lourdes Salvador Oden (11 out of 12 patents)

Core Competencies:

Cytidine Nucleotides

Protease Inhibitors

Cancer Treatment

Dioxolane Analogues

Histone Deacetylase Inhibitors

HCV Polymerase Inhibitors

Macrocyclic Inhibitors

Cysteine Protease Inhibitors

Phosphoramidate Prodrugs

Respiratory Syncytial Virus Inhibitors

Uracyl Nucleosides

Metalloproteinase Inhibitors

120 patents: Sort by Forward Citations

1. 12479870 - Base-modified cytidine nucleotides for leukemia therapy (2025-11-25),

2. 12378209 - Protease inhibitors (2025-08-05),

3. 12303521 - Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibody (2025-05-20),

4. 12221459 - Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides (2025-02-11),

5. 11951147 - SMAC mimetic (2024-04-09),

6. 11607399 - Pharmaceutical formulation for histone deacetylase inhibitors (2023-03-21),

7. 11447511 - Dioxolane analogues of uridine for the treatment of cancer (2022-09-20),

8. 11351221 - SMAC mimetic (2022-06-07),

9. 11312693 - Protease inhibitors (2022-04-26),

10. 10822360 - Dioxolane analogues of uridine for the treatment of cancer (2020-11-03),

11. 10723709 - Protease inhibitors (2020-07-28),

12. 10654877 - Dioxolane analogues of uridine for the treatment of cancer (2020-05-19),

13. 10596220 - SMAC mimetic (2020-03-24),

14. 10336780 - Dioxolane analogues of uridine for the treatment of cancer (2019-07-02),

15. 10329266 - Protease inhibitors (2019-06-25),

Medivir is a research-based pharmaceutical company with a focus on oncology. We have a leading position within protease inhibitor research and a broad product portfolio with several late-stage projects under development. Our vision is to improve the lives of people living with cancer by developing innovative therapies that target key mechanisms of tumor biology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

120 Patents

#1 in Huddinge

#65 in Sweden

#6,445 in the World

Huddinge, Sweden

Medivir Ab

Forward Citations = 803

184 inventors:

Bengt Bertil Samuelsson (19 out of 24 patents)

Pierre Jean-Marie Bernard Raboisson (18 out of 178 patents)

Bertil Samuelsson (17 out of 17 patents)

4. Urszula Grabowska (14 out of 18 patents)

5. Åsa Annica Kristina Rosenquist (14 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…